Document is current
Any future updates will be listed below
-
Authors
Byakika-Kibwika, Pauline https://orcid.org/0000-0003-0757-1968
Ssenyonga, Ronald
Lamorde, Mohammed
Blessborn, Daniel
Tarning, Joel
-
Funding
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (TA 2009.40200.020)
International Society for Infectious Diseases (077166/Z/05/Z)
- License Information
-
More Information
Article History
Received: 12 July 2019
Accepted: 22 November 2019
First Online: 3 December 2019
Ethics approval and consent to participate
: The study was approved by Makerere University School of Medicine Research and Ethics Committee (REC REF 2011–175), Uganda National Drug Authority (369/ESR/NDA/DID-12/2011), Uganda National Council for Science and Technology (HS 1031) and registered with the Pan African Clinical Trial Registry (PACTR201110000321348). All study procedures were conducted according to Good Clinical Practice standards. Patients and parents or guardians of participants provided written informed consent prior to enrollment. Study related information was provided in the participants’ local languages. The dataset supporting the conclusions of this article is included in the submission as an additional file.
: “Not applicable” in this section.
: The authors declare that they have no competing interests.
